Comerica Bank’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.78K | Sell |
367
-583
| -61% | -$4.41K | ﹤0.01% | 3457 |
|
|
2025
Q1 | $5.24K | Buy |
+950
| New | +$5.24K | ﹤0.01% | 3311 |
|
|
2024
Q2 | – | Sell |
-333
| Closed | -$5.81K | – | 3732 |
|
|
2024
Q1 | $5.81K | Buy |
+333
| New | +$5.81K | ﹤0.01% | 3306 |
|
|
2023
Q4 | – | Sell |
-75
| Closed | -$838 | – | 3760 |
|
|
2023
Q3 | $838 | Sell |
75
-710
| -90% | -$7.93K | ﹤0.01% | 3677 |
|
|
2023
Q2 | $0 | Buy |
+785
| New | – | ﹤0.01% | 840 |
|
|
2022
Q4 | $517K | Sell |
10,732
-3,360
| -24% | -$162K | ﹤0.01% | 1757 |
|
|
2022
Q3 | $641K | Sell |
14,092
-730
| -5% | -$33.2K | 0.01% | 1682 |
|
|
2022
Q2 | $755K | Sell |
14,822
-639
| -4% | -$32.5K | 0.01% | 1671 |
|
|
2022
Q1 | $1.17M | Buy |
15,461
+445
| +3% | +$33.7K | 0.01% | 1500 |
|
|
2021
Q4 | $880K | Sell |
15,016
-1,295
| -8% | -$75.9K | 0.01% | 1637 |
|
|
2021
Q3 | $1.21M | Sell |
16,311
-544
| -3% | -$40.3K | 0.01% | 1588 |
|
|
2021
Q2 | $819K | Sell |
16,855
-1,319
| -7% | -$64.1K | ﹤0.01% | 1815 |
|
|
2021
Q1 | $914K | Sell |
18,174
-644
| -3% | -$32.4K | 0.01% | 1796 |
|
|
2020
Q4 | $897K | Buy |
18,818
+81
| +0.4% | +$3.86K | 0.01% | 1778 |
|
|
2020
Q3 | $822K | Buy |
18,737
+1,532
| +9% | +$67.2K | 0.01% | 1674 |
|
|
2020
Q2 | $846K | Buy |
17,205
+1,548
| +10% | +$76.1K | 0.01% | 1614 |
|
|
2020
Q1 | $839K | Buy |
15,657
+623
| +4% | +$33.4K | 0.01% | 1458 |
|
|
2019
Q4 | $790K | Buy |
15,034
+4
| +0% | +$210 | 0.01% | 1683 |
|
|
2019
Q3 | $895K | Buy |
15,030
+107
| +0.7% | +$6.37K | 0.01% | 1588 |
|
|
2019
Q2 | $1.22M | Sell |
14,923
-690
| -4% | -$56.4K | 0.01% | 1401 |
|
|
2019
Q1 | $1.48M | Buy |
15,613
+283
| +2% | +$26.8K | 0.01% | 1328 |
|
|
2018
Q4 | $1.18M | Buy |
15,330
+78
| +0.5% | +$6K | 0.01% | 1448 |
|
|
2018
Q3 | $1.18M | Sell |
15,252
-87
| -0.6% | -$6.71K | 0.01% | 1495 |
|
|
2018
Q2 | $1.9M | Buy |
15,339
+198
| +1% | +$24.5K | 0.01% | 1299 |
|
|
2018
Q1 | $1.31M | Buy |
15,141
+436
| +3% | +$37.6K | 0.01% | 1487 |
|
|
2017
Q4 | $1.06M | Sell |
14,705
-382
| -3% | -$27.6K | 0.01% | 1605 |
|
|
2017
Q3 | $748K | Buy |
15,087
+510
| +3% | +$25.3K | 0.01% | 1741 |
|
|
2017
Q2 | $551K | Sell |
14,577
-812
| -5% | -$30.7K | ﹤0.01% | 1808 |
|
|
2017
Q1 | $478K | Buy |
15,389
+558
| +4% | +$17.3K | ﹤0.01% | 1881 |
|
|
2016
Q4 | $504K | Buy |
14,831
+862
| +6% | +$29.3K | ﹤0.01% | 1859 |
|
|
2016
Q3 | $363K | Buy |
13,969
+770
| +6% | +$20K | ﹤0.01% | 1895 |
|
|
2016
Q2 | $297K | Sell |
13,199
-395
| -3% | -$8.89K | ﹤0.01% | 1934 |
|
|
2016
Q1 | $428K | Buy |
13,594
+164
| +1% | +$5.16K | ﹤0.01% | 1812 |
|
|
2015
Q4 | $397K | Buy |
13,430
+138
| +1% | +$4.08K | ﹤0.01% | 1793 |
|
|
2015
Q3 | $480K | Buy |
+13,292
| New | +$480K | ﹤0.01% | 1727 |
|